170 related articles for article (PubMed ID: 36304505)
1. Highly Increased Levels of Inter-α-inhibitor Heavy Chain 4 (ITIH4) in Autoimmune Cholestatic Liver Diseases.
Laursen TL; Bossen L; Pihl R; Troldborg A; Sandahl TD; Hansen AG; Folserass T; Vesterhus M; Grønbæk H; Thiel S
J Clin Transl Hepatol; 2022 Oct; 10(5):796-802. PubMed ID: 36304505
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 vaccination response in patients with autoimmune hepatitis and autoimmune cholestatic liver disease.
Duengelhoef P; Hartl J; Rüther D; Steinmann S; Brehm TT; Weltzsch JP; Glaser F; Schaub GM; Sterneck M; Sebode M; Weiler-Normann C; Addo MM; Lütgehetmann M; Haag F; Schramm C; Schulze Zur Wiesch J; Lohse AW
United European Gastroenterol J; 2022 Apr; 10(3):319-329. PubMed ID: 35289983
[TBL] [Abstract][Full Text] [Related]
4. Chronic cholestatic diseases.
Poupon R; Chazouillères O; Poupon RE
J Hepatol; 2000; 32(1 Suppl):129-40. PubMed ID: 10728800
[TBL] [Abstract][Full Text] [Related]
5. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists.
Webb GJ; Rana A; Hodson J; Akhtar MZ; Ferguson JW; Neuberger JM; Vierling JM; Hirschfield GM
Clin Gastroenterol Hepatol; 2018 Feb; 16(2):278-287.e7. PubMed ID: 28993258
[TBL] [Abstract][Full Text] [Related]
6. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
Lamba M; Ngu JH; Stedman CAM
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
[TBL] [Abstract][Full Text] [Related]
7. Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis.
Dyson JK; Blain A; Foster Shirley MD; Hudson M; Rushton S; Jeffreys Jones DE
JHEP Rep; 2021 Feb; 3(1):100202. PubMed ID: 33474546
[TBL] [Abstract][Full Text] [Related]
8. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
9. The Epidemiology of UK Autoimmune Liver Disease Varies With Geographic Latitude.
Webb GJ; Ryan RP; Marshall TP; Hirschfield GM
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2587-2596. PubMed ID: 33493696
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Wilde AB; Greverath LM; Steinhagen LM; de Chamorro NW; Leicht E; Fischer J; Herta T; Berg T; Preuss B; Klein R; Tacke F; Müller T
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160133
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Overlap Syndromes in Autoimmune Liver Disease: A Systematic Review and Meta-Analysis.
Freedman BL; Danford CJ; Patwardhan V; Bonder A
J Clin Med; 2020 May; 9(5):. PubMed ID: 32414025
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of muscarinic acetylcholine receptor type 3 gene polymorphisms in patients with primary biliary cholangitis and primary sclerosing cholangitis.
Greverath LM; Leicht E; Wald de Chamorro N; Wilde AB; Steinhagen LM; Lieb C; Schmelzle M; Chopra S; Shibolet O; Fischer J; Berg T; Tacke F; Müller T
Hepatol Res; 2020 Mar; 50(3):321-329. PubMed ID: 31747477
[TBL] [Abstract][Full Text] [Related]
13. Overlap Syndromes.
Chazouillères O
Dig Dis; 2015; 33 Suppl 2():181-7. PubMed ID: 26641819
[TBL] [Abstract][Full Text] [Related]
14. Overlap syndromes among autoimmune liver diseases.
Rust C; Beuers U
World J Gastroenterol; 2008 Jun; 14(21):3368-73. PubMed ID: 18528934
[TBL] [Abstract][Full Text] [Related]
15. Overlap syndromes.
Beuers U; Rust C
Semin Liver Dis; 2005 Aug; 25(3):311-20. PubMed ID: 16143946
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
17. Mortality on the UNOS Waitlist for Patients with Autoimmune Liver Disease.
Suri JS; Danford CJ; Patwardhan V; Bonder A
J Clin Med; 2020 Jan; 9(2):. PubMed ID: 31979326
[TBL] [Abstract][Full Text] [Related]
18. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
Landi A; Weismuller TJ; Lankisch TO; Santer DM; Tyrrell DL; Manns MP; Houghton M
J Interferon Cytokine Res; 2014 Mar; 34(3):204-14. PubMed ID: 24168449
[TBL] [Abstract][Full Text] [Related]
19. S100 calcium binding protein A6 and associated long noncoding ribonucleic acids as biomarkers in the diagnosis and staging of primary biliary cholangitis.
Dong XH; Dai D; Yang ZD; Yu XO; Li H; Kang H
World J Gastroenterol; 2021 May; 27(17):1973-1992. PubMed ID: 34007134
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
Moreira RK; Revetta F; Koehler E; Washington MK
World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
